Hendrickse R G, Montefiore D
Br Med J. 1968 Oct 5;4(5622):28-30. doi: 10.1136/bmj.4.5622.28.
A field trial is reported in which good sero-conversion rates were obtained when a dose of 200 TCID(50) Beckenham 31 strain (Wellcovax) measles vaccine was administered by Ped-O-Jet subcutaneously in a volume of 0.5 ml. per dose. It is suggested that use of this reduced dosage would lead to a significant reduction in the cost per dose of the vaccine, especially when administered on a scale large enough to justify the use of multidose containers.
本文报道了一项现场试验,当使用Ped - O - Jet皮下注射0.5毫升/剂量的200个半数组织培养感染剂量(TCID50)的贝肯纳姆31株(Wellcovax)麻疹疫苗时,获得了良好的血清转化率。有人认为,使用这种减少后的剂量将导致每剂疫苗成本显著降低,特别是当大规模使用足以证明使用多剂量容器合理时。